Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy: A Model to Predict Long-term Survival
By R. Adam, V. Delvart, G. Pascal, A. Valeanu, D. Castaing, D. Azoulay, S. Giacchetti, B. Paule, F. Kunstlinger, O. Ghémard and 2 more. Annals of Surgery, 2004
1,575 citations recorded by the source corpus.
Subfields: Hepatology, Surgery
View Paper: https://www.semanticscholar.org/paper/a765a585b043c7331b8124808e4ef649695fb2bd
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Hepatology
Citations in the corpus
- Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial (2017, background): “Compared with figures in the literature for patients with liver-only disease, this percentage is relatively low and may reflect the unfavorable anatomic locations of the lesions at random assignment, which is not influenced by systemic treatment (5,6).”
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. (2016, background): “unresectable metastatic disease to resectability [168].”
- Chapter 1. General introduction (2015, neutral): “With neoadjuvant chemotherapy more patients with colorectal liver metastases can be offered a treatment with curative intent [156].”
- Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. (2005, background): “Nevertheless, a recently published long-term follow-up revealed that 23% of patients with initially unresectable liver metastases survive at 10 years and are thus considered cured by resection (compared to 30% in patients with initially resectable liver metastases) [45].”